BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27751167)

  • 1. Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents:
    McHugh CI; Lawhorn-Crews JM; Modi D; Douglas KA; Jones SK; Mangner TJ; Collins JM; Shields AF
    Cancer Imaging; 2016 Oct; 16(1):34. PubMed ID: 27751167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor imaging using 1-(2'-deoxy-2'-18F-fluoro-beta-D-arabinofuranosyl)thymine and PET.
    Tehrani OS; Muzik O; Heilbrun LK; Douglas KA; Lawhorn-Crews JM; Sun H; Mangner TJ; Shields AF
    J Nucl Med; 2007 Sep; 48(9):1436-41. PubMed ID: 17785728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabeled 2'-fluorodeoxyuracil-beta-D-arabinofuranoside (FAU) and 2'-fluoro-5-methyldeoxyuracil-beta -D-arabinofuranoside (FMAU) as tumor-imaging agents in mice.
    Wang H; Oliver P; Nan L; Wang S; Wang Z; Rhie JK; Zhang R; Hill DL
    Cancer Chemother Pharmacol; 2002 May; 49(5):419-24. PubMed ID: 11976837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil in mice bearing colorectal cancer xenografts: rationale for therapeutic use and as a positron emission tomography probe for thymidylate synthase.
    Eiseman JL; Brown-Proctor C; Kinahan PE; Collins JM; Anderson LW; Joseph E; Hamburger DR; Pan SS; Mathis CA; Egorin MJ; Klecker RW
    Clin Cancer Res; 2004 Oct; 10(19):6669-76. PubMed ID: 15475457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracking cellular stress with labeled FMAU reflects changes in mitochondrial TK2.
    Tehrani OS; Douglas KA; Lawhorn-Crews JM; Shields AF
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1480-8. PubMed ID: 18265975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat studies comparing 11C-FMAU, 18F-FLT, and 76Br-BFU as proliferation markers.
    Lu L; Samuelsson L; Bergström M; Sato K; Fasth KJ; Långström B
    J Nucl Med; 2002 Dec; 43(12):1688-98. PubMed ID: 12468521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells.
    Plotnik DA; Emerick LE; Krohn KA; Unadkat JD; Schwartz JL
    J Nucl Med; 2010 Sep; 51(9):1464-71. PubMed ID: 20720049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging [18F]FAU [1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl) uracil] in dogs.
    Sun H; Collins JM; Mangner TJ; Muzik O; Shields AF
    Nucl Med Biol; 2003 Jan; 30(1):25-30. PubMed ID: 12493539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([18F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-D: -FMAU and [18F]FLT.
    Nishii R; Volgin AY; Mawlawi O; Mukhopadhyay U; Pal A; Bornmann W; Gelovani JG; Alauddin MM
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):990-8. PubMed ID: 18057932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FEAU as a radiotracer for herpes simplex virus thymidine kinase gene expression: in-vitro comparison with other PET tracers.
    Buursma AR; Rutgers V; Hospers GA; Mulder NH; Vaalburg W; de Vries EF
    Nucl Med Commun; 2006 Jan; 27(1):25-30. PubMed ID: 16340720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [
    Vaishampayan UN; Tehrani OS; Lawhorn-Crews JM; Heilbrun LK; Dobson K; Smith D; Dickow B; Shields AF
    Mol Imaging Biol; 2017 Dec; 19(6):810-816. PubMed ID: 28289967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.
    Schwartz JL; Tamura Y; Jordan R; Grierson JR; Krohn KA
    J Nucl Med; 2003 Dec; 44(12):2027-32. PubMed ID: 14660729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer.
    Sun H; Sloan A; Mangner TJ; Vaishampayan U; Muzik O; Collins JM; Douglas K; Shields AF
    Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):15-22. PubMed ID: 15586282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy.
    Pio BS; Park CK; Pietras R; Hsueh WA; Satyamurthy N; Pegram MD; Czernin J; Phelps ME; Silverman DH
    Mol Imaging Biol; 2006; 8(1):36-42. PubMed ID: 16362149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies.
    Sun H; Collins JM; Mangner TJ; Muzik O; Shields AF
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):343-8. PubMed ID: 16001172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
    Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
    Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.
    Everitt S; Hicks RJ; Ball D; Kron T; Schneider-Kolsky M; Walter T; Binns D; Mac Manus M
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1098-104. PubMed ID: 19386444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
    Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH
    Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate Synthase.
    Li J; Kim S; Shields AF; Douglas KA; McHugh CI; Lawhorn-Crews JM; Wu J; Mangner TJ; LoRusso PM
    J Clin Pharmacol; 2016 Nov; 56(11):1433-1447. PubMed ID: 27095537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Journey of 2'-deoxy-2'-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FMAU): from Antiviral Drug to PET Imaging Agent.
    Alauddin MM
    Curr Med Chem; 2018; 25(16):1867-1878. PubMed ID: 29189119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.